Hepatitis C Elimination During a Global Pandemic: A Case Study of Resilience in Action. (July 2022)
- Record Type:
- Journal Article
- Title:
- Hepatitis C Elimination During a Global Pandemic: A Case Study of Resilience in Action. (July 2022)
- Main Title:
- Hepatitis C Elimination During a Global Pandemic: A Case Study of Resilience in Action
- Authors:
- Facente, Shelley N.
Grinstein, Rachel
Broussard, Janessa
Shost, Jessica
Azari, Soraya
Siruno, Jennifer
Jimenez, Jose A.
Luetkemeyer, Anne F.
Burk, Katie - Abstract:
- Until the COVID-19 pandemic, San Francisco's hepatitis C virus (HCV) elimination initiative, End Hep C SF, was expanding and refining HCV testing and treatment strategies citywide, making progress toward local HCV elimination goals. Although a shelter-in-place health order issued in March 2020 categorized HCV testing as an "essential service, " most HCV testing and treatment immediately stopped until COVID-19–safe protocols could be implemented. During the 14 months of pandemic-related organizational closures, End Hep C SF transitioned to a 100% virtual model, maintaining regularly scheduled meetings. Community-based HCV antibody testing decreased 80% from February to April 2020, and HCV treatment initiation also decreased, although both services started to rebound in mid-to-late 2020, partially as a result of End Hep C SF collaborations. End Hep C SF service providers, clinicians, and advocates reported that the continuous communication and common agenda of End Hep C SF—2 principles of the collective impact initiative—served as a familiar touchpoint and helpful source of information during this isolating and uncertain time. Ultimately, End Hep C SF allowed us to continue HCV elimination strategies through 6 lessons learned: maintaining HCV treatment access through telehealth and mobile services; leveraging research studies that provided HCV testing and treatment; offering HCV screening and linkage to care in tandem with COVID-19–related initiatives; being flexible andUntil the COVID-19 pandemic, San Francisco's hepatitis C virus (HCV) elimination initiative, End Hep C SF, was expanding and refining HCV testing and treatment strategies citywide, making progress toward local HCV elimination goals. Although a shelter-in-place health order issued in March 2020 categorized HCV testing as an "essential service, " most HCV testing and treatment immediately stopped until COVID-19–safe protocols could be implemented. During the 14 months of pandemic-related organizational closures, End Hep C SF transitioned to a 100% virtual model, maintaining regularly scheduled meetings. Community-based HCV antibody testing decreased 80% from February to April 2020, and HCV treatment initiation also decreased, although both services started to rebound in mid-to-late 2020, partially as a result of End Hep C SF collaborations. End Hep C SF service providers, clinicians, and advocates reported that the continuous communication and common agenda of End Hep C SF—2 principles of the collective impact initiative—served as a familiar touchpoint and helpful source of information during this isolating and uncertain time. Ultimately, End Hep C SF allowed us to continue HCV elimination strategies through 6 lessons learned: maintaining HCV treatment access through telehealth and mobile services; leveraging research studies that provided HCV testing and treatment; offering HCV screening and linkage to care in tandem with COVID-19–related initiatives; being flexible and inventive, such as administering HCV treatment to residents of shelter-in-place hotels; establishing a data dashboard to track HCV testing and treatment; and relying on partnerships to solve problems and avoid burnout. … (more)
- Is Part Of:
- Public health reports. Volume 137:Number 4(2022)
- Journal:
- Public health reports
- Issue:
- Volume 137:Number 4(2022)
- Issue Display:
- Volume 137, Issue 4 (2022)
- Year:
- 2022
- Volume:
- 137
- Issue:
- 4
- Issue Sort Value:
- 2022-0137-0004-0000
- Page Start:
- 649
- Page End:
- 654
- Publication Date:
- 2022-07
- Subjects:
- hepatitis C -- HCV -- elimination -- screening -- treatment -- COVID-19 -- pandemic -- resilience
Public health -- United States -- Periodicals
614.0973 - Journal URLs:
- http://purl.access.gpo.gov/GPO/LPS23348 ↗
http://www.jstor.org/journals/00333549.html ↗
http://www.publichealthreports.org/archives/archives.cfm ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=347&action=archive ↗
https://uk.sagepub.com/en-gb/eur/public-health-reports/journal202574 ↗
http://www.sagepublications.com/ ↗
http://firstsearch.oclc.org ↗ - DOI:
- 10.1177/00333549221083741 ↗
- Languages:
- English
- ISSNs:
- 0033-3549
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6965.000000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22853.xml